image
Anebulo Pharmaceuticals, Inc. ANEB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.5884
4.5 %
$ 41.2 M
Market Cap
-4.96
P/E
BALANCE SHEET
4.07 M ASSETS
-65.10%
Growth Rates
1Year -65.10%
3Years -42.70%
5Years 0.00%
7Years 0.00%
10Years 0.00%
261 K LIABILITIES
-75.62%
Growth Rates
1Year -75.62%
3Years 2.55%
5Years 0.00%
7Years 0.00%
10Years 0.00%
3.81 M EQUITY
-64.04%
Growth Rates
1Year -64.04%
3Years -43.74%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Anebulo Pharmaceuticals, Inc.
image
Current Assets 3.51 M
Cash & Short-Term Investments 3.09 M
Receivables 0
Other Current Assets 414 K
Non-Current Assets 565 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 565 K
Current Liabilities 261 K
Accounts Payable 156 K
Short-Term Debt 0
Other Current Liabilities 104 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020
ASSETS
Cash & Cash Equivalents 3.1 11.2 14.5 20.0 3.0
Short Term Investments 0 0 0 0 0
Receivables 0 0 0 0 3.5 K
Inventory 0 0 0 0 3.5
Other Current Assets 0.4 0.4 1.0 1.7 0
Total Current Assets 3.5 11.2 14.5 20.0 3.0
PP&E 0 0 0 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 0.6 0 0 0 0
Other Assets 0 0.4 0 0 0
Total Assets 4.1 11.7 15.6 21.7 3.0
LIABILITIES
Accounts Payable 0.2 0.5 0.4 0.1 0
Short Term Debt 0 0 0 0 0.2
Other Current Liabilities 0.1 0.5 0.1 0.1 22.6 K
Total Current Liabilities 0.3 0.5 0.5 0.2 0.2
Long Term Debt 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 0 0
Total Liabilities 0.3 1.1 0.5 0.2 3.2
EQUITY
Common Stock 25.9 K 25.6 K 23.3 K 23.3 K 12 K
Retained Earnings (65.4) (57.2) (45.5) (38.6) (0.2)
Other Accumulative Comprehensive Income/Loss 0 0 0 (21.7) (3.0)
Total Equity 3.8 10.6 15.1 21.4 (0.2)
Total Liabilities and Equity 4.1 11.7 15.6 21.7 3.0
SHARES OUTSTANDING
Common Shares Outstanding 25.8 25.1 23.3 23.3 23.7